2:1 Bonus Issue Alert! Thyrocare Announces First-Ever Bonus Shares With Interim Dividend Amid Q2 Profit Jump

Thyrocare Technologies, one of India's leading diagnostic and preventive healthcare service providers, has announced its first-ever bonus issue of equity shares, signaling a major milestone in its journey as a publicly listed company. while announcing its Q2 FY26 results, along with an interim dividend.

2:1 Bonus Issue: Thyrocare Announces First-Ever Bonus Shares For Q2FY26

As per the announcement, shareholders will receive two bonus shares for every one share held as on the record date, which is yet to be disclosed.

This bonus issue is a first in the company's history and reflects Thyrocare's confidence in its future growth and financial stability. Since its listing in 2016, the company has distributed Rs 143.5 per share in total dividends to shareholders but had not previously issued any bonus shares.

"We are pleased to report a robust set of results for the quarter and the announcement of our bonus issue on the occasion of 25 years of Thyrocare coinciding with the auspicious occasion of Diwali. These numbers underscore our continued focus on operational excellence, network expansion, and value-driven diagnostics," Rahul Guha, MD & CEO, Thyrocare Technologies Ltd

Thyrocare Interim Dividend: Check Payout, Record Date and Other Key Details

In addition to the bonus issue, the company has also declared an interim dividend of Rs 7 per share, further enhancing returns for its investors. The record date for the interim dividend has been fixed as Friday, October 24, 2025.

Thyrocare Q2 Results Today: Net Profit Surges 82% YoY; Revenue Up 22%, Margins Expand to 32.9%

Thyrocare Technologies Ltd delivered a robust performance for the July-September quarter, with net profit soaring 82% year-on-year to Rs 47.90 crore, driven by a surge in test volumes and enhanced operational efficiency.

The company's revenue rose 22%, reaching Rs 216.5 crore, up from Rs 177.4 crore in the same period last year. EBITDA witnessed a sharp 47.5% growth, coming in at Rs 71.3 crore, reflecting strong cost management and scale efficiencies. As a result, operating margins expanded significantly to 32.9%, compared to 27.2% in the year-ago quarter,

Despite these developments, shares of Thyrocare Technologies ended almost unchanged on Tuesday at Rs 1,264.6. However, the stock has seen a 6.3% rise over the past month.

Disclaimer